IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).

Translated title of the contribution: IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).

A. Patel, I. Cheng, F. Canzian, L. LeMarchand, M.J. Thun, C.D. Berg, J.E. Buring, E.E. Calle, S. Chanock, F. Clavel-Chapelon, D.G. Cox, M. Dorronsoro, L. Dossus, C.A. Haiman, S.E. Hankinson, B.E. Henderson, R. Hoover, D.J. Hunter, R. Kaaks, L.N. KolonelP. Kraft, J. Linseisen, E. Lund, J. Manjer, C. McCarty, P.H.M. Peeters, M.C. Pike, M. Pollak, E. Riboli, D.O. Stram, A. Tjonneland, R.C. Travis, D. Trichopoulos, R. Tumino, M. Yeager, R. Ziegler, H.S. Feigelson

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionIGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
Original languageUndefined/Unknown
Pages (from-to)2578
Number of pages1
JournalPLoS ONE [E]
Volume3
Issue number7
Publication statusPublished - 2008

Cite this